| Bioactivity | Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy. |
| Invitro | Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy[1]. |
| Name | Fonadelpar |
| CAS | 515138-06-4 |
| Formula | C25H23F3N2O4S |
| Molar Mass | 504.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kobayashi, et al. Therapeutic agent for neuroparalytic keratopathy containing benzisoxazol compound-based PPARδ agonist. WO2016199871A1. |